News - Orexo AB


Current filters:

Orexo AB

Popular Filters

Orexo gets US FDA approval for opioid dependence drug Zubsolv


Swedish drug developer Orexo (STO: ORX) today (July 4) received approval from the US Food and Drug Administration…

Orexo ABPharmaceuticalReckitt BenckiserRegulationSuboxoneZubsolv

Sweden's Orexo in respiratory research accord with AstraZeneca


Swedish drug developer Orexo AB (STO: ORX) has entered into an agreement with Anglo-Swedish drug major…

AstraZenecaLicensingOrexo ABOX-CLIPharmaceuticalResearchRespiratory and Pulmonary

Orexo to explore strategic alternatives for commercialization in the USA


Swedish specialty pharmaceutical company Orexo (STO:ORX), with a focus on innovative sublingual drug…

AbstralLicensingMarkets & MarketingNeurologicalNorth AmericaOrexo ABPharmaceuticalReckitt BenckiserSuboxoneZubsolv

Orexo and ProStrakan reconfigure rights to Abstral


Sweden's Orexo AB (STO: ORX) and Scotland-based ProStrakan, a subsidiary of Japanese drugmaker Kyowa…

AbstralGlobalKyowa Hakko KirinLicensingOncologyOrexo ABPharmaceuticalProStrakan

Janssen drops deal with Orexo for OX-CLI/OX-ESI


US health care major Johnson & Johnson INYSE: JNJ) subsidiary Janssen has decided to end research collaboration…

FinancialJanssenJohnson & JohnsonLicensingOrexo ABPharmaceuticalRespiratory and Pulmonary

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top